VIDEO: Valeant Senior Official Leaves Amid Allergan Takeover Battle

An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . Valeant confirmed late on Friday after inquiries by Reuters, Executive vice-president and company group chairman Ryan Weldon will leave. Like Chief Executive Mike Pearson, Weldon previously worked for management consulting firm McKinsey & Co. Valeant said Weldon's departure was planned, and takes effect after it completes a $1.4 billion sale of several injectable treatments to Nestle SA .



[grabpress_video guid=85605e3c297fbfddfac75b71d829946341ae16f9 embed_id=2156007]

Thanks for checking us out. Please take a look at the rest of our videos and articles.

To stay in the loop, bookmark our homepage.